Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. We are developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
VAX-31, our 31-valent pneumococcal conjugate vaccine (PCV) candidate advancing to a Phase 3 adult clinical program and currently being evaluated in a Phase 2 infant clinical program, is being developed for the prevention of invasive pneumococcal disease (IPD) in adults and infants and is the broadest-spectrum PCV candidate in the clinic today. VAX-24, our 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market and is currently being evaluated in a Phase 2 infant study. Both VAX-31 and VAX-24 are designed to improve upon the standard-of-care PCVs by covering the serotypes in circulation that are responsible for a significant portion of IPD and are associated with high case-fatality rates, antibiotic resistance and meningitis, while maintaining coverage of previously circulating strains that are currently contained through continued vaccination practice.
We are re-engineering the way highly complex vaccines are made. Unlike conventional cell-based approaches, our system for producing difficult-to-make proteins and antigens is intended to accelerate our ability to efficiently create and deliver high-fidelity vaccines with enhanced immunological benefits.
In addition to our PCV franchise, our pipeline includes early-stage programs targeting Group A Strep, periodontitis and Shigella. At Vaxcyte, we are driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.
Company Details
- Employees
- 492
- Founded
- -
- Address
- 825 Industrial Rd,
- Phone
- (650) 837-0111
- in****@****yte.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- vaxcyte.com
- HQ
- San Carlos, California
Vaxcyte Questions
Vaxcyte's helpline number is (650) 837-0111
Vaxcyte's website is vaxcyte.com
Vaxcyte's LinkedIn profile is https://www.linkedin.com/company/vaxcyte
Vaxcyte has
492 employees.
View email and phone details for 492
employees at Vaxcyte.
Vaxcyte's industry is
Biotechnology Research
Vaxcyte's top competitors are
Denali Therapeutics,
Biomarin Pharmaceutical Inc.,
Cytokinetics,
Gilead Sciences,
Arsenal Biosciences, Inc.,
Revolution Medicines,
Travere Therapeutics,
Sutro Biopharma, Inc.,
Genentech,
Orsobio.
Vaxcyte's support email address is info@vaxcyte.com
Vaxcyte's categories are Biotechnology Research
Vaxcyte's founding year is 2013
